> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Royal Philips Wearable Light Therapy
- URL: https://www.fdaweb.com/fda-clears-royal-philips-wearable-light-therapy/
- Published: 2017-07-13T12:00:00.000Z
- Updated: 2026-09-14T22:34:13.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5139124

FDA has cleared a Royal Philips 510(k) for the Philips BlueControl wearable light therapy device to treat mild psoriasis. “Clinical studies have demonstrated that the UV-free blue LED light emitted by Philips’ BlueControl wearable device induces natural, drug-free processes in the skin to significantly reduce symptoms of mild psoriasis vulgaris — the most common form of psoriasis — such as redness, scaling and thickness of psoriasis plaques,” the company says. It is designed for patients to wear the rechargeable, battery-powered device on affected areas such as the arms, legs, elbows and knees using its adjustable straps, the company says.